Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Prostatic Neoplasms 12Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Thromboembolism 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Somatostatinoma 1Small Cell Lung Carcinoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Coronary Artery Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Trastuzumab 2Everolimus 2vatalanib 1tipifarnib 1pentetreotide 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulinoma × High-Energy Shock Waves × Genitourinary × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡